EUVIMEDEUVIMED entdecken
Übersichtsarbeit

tRNA ‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression

Jingjing Lu iD, Ping Zhu, Xiufen Zhang iD, Linzi Zeng, Bujie Xu, Ping Zhou iD

International Journal of Cancer · 2024

DOI: 10.1002/ijc.35041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Jingjing Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Neoplasms, RNA, Transfer, Disease Progression, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

tRNA‐derived fragments (tRFs) are novel small noncoding RNAs (sncRNAs) that range from approximately 14 to 50 nt. They are generated by the cleavage of mature tRNAs or precursor tRNAs (pre‐tRNAs) at specific sites. Based on their origin and length, tRFs can be classified into three categories: (1) tRF‐1 s; (2) tRF‐3 s, tRF‐5 s, and internal tRFs (i‐tRFs); and (3) tRNA halves. They play important roles in stress response, signal transduction, and gene expression processes. Recent studies have identified differential expression of tRFs in various tumors. Aberrantly expressed tRFs have critical clinical value and show promise as new biomarkers for tumor diagnosis and prognosis and as therapeutic targets. tRFs regulate the malignant progression of tumors via various mechanisms, primarily including modulation of noncoding RNA biogenesis, global chromatin organization, gene expression regulation, modulation of protein translation, regulation of epigenetic modification, and alternative splicing regulation. In conclusion, tRF‐mediated regulatory pathways could present new avenues for tumor treatment, and tRFs could serve as promising therapeutic targets for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRNA, TransferDisease ProgressionGene Expression Regulation, NeoplasticHumansRNA, Small UntranslatedAnimalsBiomarkers, TumorEpigenesis, Genetic

Stichwörter der Autor:innen

small noncoding RNAtRNA‐derived fragmentstumor

Substanzen

RNA, TransferRNA, Small UntranslatedBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Clinical Medical Research Center, Affiliated Hospital of Nantong University, Nantong, China.
  • Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Oncology Institute, Affiliated Hospital of Jiangnan University, Wuxi, China.

ORCID-Profile: Jingjing Lu, Xiufen Zhang, Ping Zhou

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Lu, J., Zhu, P., Zhang, X., Zeng, L., Xu, B., & Zhou, P. (2024). tRNA ‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression. International Journal of Cancer. https://doi.org/10.1002/ijc.35041

Vancouver

Lu J, Zhu P, Zhang X, Zeng L, Xu B, Zhou P. tRNA ‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression. International Journal of Cancer. 2024. doi:10.1002/ijc.35041

BibTeX
@article{Lu2024,
  author = {Lu, Jingjing and Zhu, Ping and Zhang, Xiufen and Zeng, Linzi and Xu, Bujie and Zhou, Ping},
  title = {tRNA ‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.35041}
}
Kostenlos starten →